Italia markets open in 8 hours 52 minutes

Becton, Dickinson and Company (BDX)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
246,14+2,02 (+0,83%)
Alla chiusura: 04:00PM EST
246,14 0,00 (0,00%)
Dopo ore: 05:33PM EST

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800
https://www.bd.com

Settore/iHealthcare
SettoreMedical Instruments & Supplies
Impiegati a tempo pieno75.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Thomas E. Polen Jr.Pres, CEO & Chairman2,11M1,72M1973
Mr. Christopher R. ReidyExec. VP & Chief Admin. Officer1,4MN/D1957
Mr. Samrat S. Khichi Esq.Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel2,19MN/D1967
Mr. Alberto MasExec. VP & Pres of the Medical Segment1,15M1,64M1961
Mr. Christopher DelOreficeExec. VP & CFON/DN/D1971
Mr. Thomas J. SpoerelSr. VP, Controller & Chief Accounting OfficerN/DN/D1978
Ms. Elizabeth McCombsExec. VP & Chief Technology OfficerN/DN/D1976
Jerry FlaszExec. VP of Global Services & Chief Information OfficerN/DN/DN/D
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory BoardN/DN/DN/D
Ms. Francesca M. DeMartinoSr. VP of Investor RelationsN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Governance aziendale

L'ISS Governance QualityScore di Becton, Dickinson and Company al 26 settembre 2021 è 9. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 7; diritti degli azionisti: 10; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.